Back to 
RA Capital Management, L.P.
RA Capital Management, L.P.
STRO
Showing 2 of 7 quarters
Position history for RA Capital Management, L.P.'s holdings in Sutro Biopharma, Inc.
No. RA Capital Management exited its STRO (Sutro Biopharma) position in Q2 2025. Its Q1 2025 13F listed 4,434,637 shares worth $2.9M. RA Capital Management first reported STRO in Q2 2020 and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2.9M
Total Shares Change
-4.4M
Quarter-by-Quarter History